-
Grade 7: £36,024- £44,263 per annum Location: John Radcliffe Hospital Contract type: Fixed term until 31 December 2026 Hours: Full-time About the role The Nuffield Department of Surgical Science is seeking a qualified Postdoctoral Research Fellow to join the IDEAL Collaboration research group...
-
The Bonavero Institute of Human Rights is seeking to recruit an outstanding legal scholar in business and human rights with demonstrable research expertise in an aspect of business and human rights
-
Contract type: Fixed term for until May 2025 Hours: Full-time About the role We are looking for a Human Factors Research Fellow to work on the RESPOND Programme within the Quality, Reliability
-
The Bonavero Institute of Human Rights is seeking to recruit a full-time Programmes Manager and Research Fellow who will build upon and develop strong links between the Bonavero Institute and
-
to the establishment of an Institute for Ethics in AI, to be based in the Stephen A. Schwarzman Centre for the Humanities, under the aegis of the Faculty of Philosophy. The Institute builds upon the University’s world
-
We are looking to appoint a Senior Research Fellow to join the Department of Statistics and the Oxford-Man Institute of Quantitative Finance (OMI). The postholder will split their time roughly 40/60
-
will be considered. The ideal candidate will hold a PhD (or be near completion) in sociology, anthropology, human geography, development studies, politics, or area studies related to Japanese societies
-
? The role would suit researchers with a strong background in education and in the disciplines of sociology, history, anthropology, or human geography. The project is particularly looking for candidates with
-
proposed will be based on Human Factors science and the programme will culminate in a 24 hospital randomised Stepped Wedge trial. The postholder will be working closely with Professor Peter McCulloch and his
-
Ebola. The team are running pioneering studies on experimental controlled human challenge studies for bacterial and viral infections and phase I-III studies of experimental vaccines to transform human